Search

Search results

202 results found

Directions to Our Center

Mailing Address: 330 Brookline Ave. E/RW-453 Boston, MA 02115 Directions to Beth Israel Deaconess Medical Center via MBTA Subway and Buses: From Kenmore: Take bus #8 (JFK/UMass or Dudley) OR #60 (Chestnut Hill) OR #65 Brighton Center. These buses stop in front of the Main Entrance of BIDMC East...

Dark-Blood LGE

Imaging of the Myocardial Scar Using 3D Fat-Suppressed Dark-Blood LGEImaging of the myocardial scar and fibrosis is essential for proper diagnosis and treatment planning of several heart diseases. Late Gadolinium Enhanced (LGE) MRI is a standard imaging technique commonly used for that purpose...

Ulf Neisius M.D., Ph.D.

EDUCATION:2007– 2011: Ph.D. Institute of Cardiovascular and Medical Sciences,University of Glasgow, Glasgow, United Kingdom1998– 2004: M.D. Hannover Medical School, Hannover, Germany RESEARCH INTERESTS: Cardiac imaging including echocardiography and cardiac resonance imaging, subclinical...

Maryam Nezafat, Ph.D.

EDUCATION: 2013-2017: Ph.D. Medical Imaging and Biomedical Engineering, King’s College London, London UK.2011-2012: MRs Medical Imaging and Biomedical Engineering, King’s College London, London UK. RESEARCH INTERESTS: My research interests are in cardiac MRI, pulse sequence design and scanning...

Hossam El-Rewaidy

EDUCATION: 10/2013 – 08/2016: MSc in Biomedical Engineering. Cairo University, Giza, Egypt. Systems and Biomedical Engineering Department, Faculty of Engineering.09/2007 – 08/2012: BSc in Electrical Systems and Biomedical Engineering Cairo University, Giza, Egypt. Systems and Biomedical Engineering...

Carolina Brunnett

EDUCATION: 10/2015 – Current : MSc (in progress) Department of Computer Science Technical University of Munich, Munich, Germany Robotics, Cognition, Intelligence, 10/2012 – 09/2015 : BSc Economathematics: University of Cologne, Cologne, Germany. Department of Mathematics RESEARCH INTERESTS: I have a...

A Pilot Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-Associated Ocular Surface Disease

Kheirkhah, Ahmad, Antonio Di Zazzo, Vannarut Satitpitakul, Merle Fernandez, Daniel Magilavy, and Reza Dana. 2017. “A Pilot Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-Associated Ocular Surface Disease”. Cornea 36 (7): 799-804.